SNDX

SNDX Operating Income Growth

42.73%TTM

Period ending:

SNDX TTM Operating Income YoY %%
SNDX TTM Operating Income YoY %1992.78%-17186.65%
2014-09-302026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

SNDX operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 48 observations from Sep 30, 2014 to Jun 30, 2026.

Syndax Pharmaceuticals Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
42.7312%
35.0046%
19.6036%
4.4553%
-17.7305%
-30.5418%
-47.7137%
-65.5041%
-66.5963%
-63.7233%
-51.5281%
-1,288.8722%
-15,330.5727%
-1,073.7549%
-678.7796%
84.3672%
101.2723%
119.7937%
136.7109%
-35.9156%
-51.0396%
-44.3695%
-24.1297%
-4.9484%
12.3146%
18.4786%
24.1671%
17.5781%
8.5256%
-3.5139%
-22.4715%
-41.8349%
-37.9022%
-42.2038%
-41.5574%
-43.7004%
-91.2262%
-94.0641%
-113.3574%
-95.074%
-32.9651%
-13.9972%
3.8393%
8.5986%
-35.7531%
-93.7472%
-148.8858%
-267.503%

Compare operating income growth

All SNDX financial metrics · SNDX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.